Hims & Hers Health has the GF Score of 58, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Hims & Hers Health
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Hims & Hers Health (MEX:HIMS) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Hims & Hers Health GF Score Related Terms
MEX:HIMS vs LNTH, LQDA, ALKS: GF Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hims & Hers Health GF Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's GF Score distribution charts can be found below:
* The bar in red indicates where Hims & Hers Health's GF Score falls into.
Hims & Hers Health (MEX:HIMS) has a GF Score of 58 as of Jul. 03, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Hims & Hers Health and its competitors. This is 21% above median its historical median of 48.00. Over the past decade, Hims & Hers Health's GF Score has ranged from 19.00 to 58.00.
Is Hims & Hers Health's GF Score too high?
Hims & Hers Health's current GF Score of 58 is 21% above median its 10-year median of 48.00. Over the past 10 years, this metric has ranged from a low of 19.00 to a high of 58.00. Overall, Hims & Hers Health has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's GF Score compare to LNTH and LQDA?
Hims & Hers Health's GF Score of 58 can be compared against companies in the Drug Manufacturers industry. Historically, Hims & Hers Health's own GF Score has ranged from 19.00 to 58.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current GF Score is 58, which is 21% above median its own 10-year median of 48.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (MEX:HIMS) is currently considered Fairly Valued. The stock's GF Value™ is MXN676.39, compared to a current price of MXN638.40 — trading 5.6% below its estimated fair value. The current GF Score is 58, which is 21% above median its 10-year median of 48.00. Hims & Hers Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Hims & Hers Health (MEX:HIMS), the current GF Score is 58 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hims & Hers Health (MEX:HIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued.
The current stock price of MXN638.40 is trading 5.6% below its estimated GF Value™ of MXN676.39.
GuruFocus considers Hims & Hers Health to be Fairly Valued.
Key valuation signals for MEX:HIMS:
GF Score: 58 (21% above median its 10-year median of 48.00)
GF Value™: MXN676.39 vs. price of MXN638.40 (5.6% below fair value)
No single metric tells the full story. See the MEX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
58GF Score
Get the complete analysis for MEX:HIMS
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:HIMS has been successfully added to your 